PubRank

D J Shale

Author PubWeight™ 72.53‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cystic fibrosis: current survival and population estimates to the year 2000. Thorax 1991 7.12
2 Elective versus symptomatic antibiotic treatment in cystic fibrosis patients with chronic Pseudomonas infection of the lungs. Thorax 2000 2.31
3 Attaining a correct diagnosis of COPD in general practice. Respir Med 2004 1.97
4 Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001 1.94
5 Trial of ketoconazole in non-invasive pulmonary aspergillosis. Thorax 1987 1.90
6 Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor. J Thorac Cardiovasc Surg 1993 1.57
7 Increased augmentation index in patients with cystic fibrosis. Eur Respir J 2009 1.51
8 Cystic fibrosis. 2. Lung injury in cystic fibrosis. Thorax 1990 1.37
9 Plasma tumour necrosis factor alpha in cystic fibrosis. Thorax 1991 1.30
10 IgG antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis. Arch Dis Child 1992 1.26
11 Diagnostic criteria for adult respiratory distress syndrome: time for reappraisal. Lancet 1989 1.23
12 Circulating immunoreactive interleukin-6 in cystic fibrosis. Am J Respir Crit Care Med 1998 1.20
13 Bone density, body composition, and inflammatory status in cystic fibrosis. Am J Respir Crit Care Med 2000 1.17
14 Insulin resistance and inflammation - A further systemic complication of COPD. COPD 2007 1.08
15 Inflammatory markers in cystic fibrosis. Respir Med 1991 1.07
16 In vitro displacement of vasoactive mediators from plasma proteins: a possible mechanism for pseudo-allergic reactions to neuromuscular blocking drugs. Br J Anaesth 1992 1.07
17 The evaluation of a quantitative enzyme-linked immunosorbent assay (ELISA) for anti-Aspergillus fumigatus IgG. J Immunol Methods 1985 1.07
18 Pseudomonas aeruginosa antibodies in blood spots from patients with cystic fibrosis. Arch Dis Child 1989 1.06
19 Tumour necrosis factor-alpha, resting energy expenditure and cachexia in cystic fibrosis. Clin Sci (Lond) 1993 1.02
20 Pulmonary vascular permeability to transferrin in the pulmonary oedema of renal failure. Thorax 1987 1.02
21 Resting energy expenditure and oxygen cost of breathing in patients with cystic fibrosis. Thorax 1996 1.01
22 Metabolic and inflammatory responses to pulmonary exacerbation in adults with cystic fibrosis. Eur J Clin Invest 2000 1.00
23 Inspiratory muscle function and body composition in cystic fibrosis. Am J Respir Crit Care Med 1998 1.00
24 Subclinical right ventricular dysfunction in cystic fibrosis. A study using tissue Doppler echocardiography. Am J Respir Crit Care Med 2001 0.98
25 Predicting survival in cystic fibrosis. Thorax 1997 0.93
26 Cystic fibrosis: inflammatory response to infection with Burkholderia cepacia and Pseudomonas aeruginosa. Eur Respir J 1999 0.90
27 Host inflammatory responses to first isolation of Pseudomonas aeruginosa from sputum in cystic fibrosis. Pediatr Pulmonol 1993 0.90
28 The host inflammatory response prior to death in patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection. Respir Med 1993 0.90
29 In vitro tumor necrosis factor-alpha secretion by monocytes from patients with cystic fibrosis. Am J Respir Cell Mol Biol 1992 0.89
30 Heart-lung transplantation in cystic fibrosis: predictions for the next decade in England and Wales. Respir Med 1994 0.88
31 Dopamine is a physiological regulator of thyrotrophin (TSH) secretion in normal man. Clin Endocrinol (Oxf) 1979 0.88
32 Tumour necrosis factor alpha in severe congestive cardiac failure. Br Heart J 1993 0.87
33 Altered tissue distribution in adults with cystic fibrosis. Thorax 2003 0.85
34 Coeliac disease in monozygotic twins. Postgrad Med J 1982 0.85
35 What community measurements can be used to predict bone disease in patients with COPD? Respir Med 2008 0.84
36 Circulating matrix metalloproteinase-9 and osteoporosis in patients with chronic obstructive pulmonary disease. Chron Respir Dis 2009 0.84
37 Mucus hypersecretion: a common symptom, a common mechanism? Eur Respir J 2004 0.83
38 Inflammatory markers of lower respiratory tract infection in elderly people. Age Ageing 1994 0.83
39 Neutrophil degranulation and increased pulmonary capillary permeability following oesophagectomy: a model of early lung injury in man. Br J Surg 1988 0.82
40 Antibody response to Burkholderia cepacia in patients with cystic fibrosis colonized with Burkholderia cepacia and Pseudomonas aeruginosa. J Infect 2000 0.81
41 C-reactive protein is not a useful indicator of intermittent bacterial colonization in early lung disease of patients with cystic fibrosis. Pediatr Pulmonol 1994 0.81
42 An assessment of a double-isotope method for the detection of transferrin accumulation in the lungs of patients with widespread pulmonary infiltrates. Clin Sci (Lond) 1988 0.80
43 A rapid radioassay for human IgG produced in lymphocyte in vitro culture systems. J Immunol Methods 1981 0.80
44 C-reactive protein measured in dried blood spots from patients with cystic fibrosis. J Immunol Methods 1991 0.80
45 Totally implantable venous access devices in adult patients with cystic fibrosis. Respir Med 1996 0.80
46 Pulmonary oedema and renal failure. Nephrol Dial Transplant 1988 0.79
47 Systemic inflammatory responses to cardiopulmonary bypass: a pilot study of the effects of pentoxifylline. Respir Med 1993 0.79
48 Precipitins and specific IgG antibody to Aspergillus fumigatus in a chest unit population. Thorax 1992 0.79
49 Evidence for dopaminergic control of thyrotrophin secretion in man. Lancet 1977 0.79
50 Angiotensin converting enzyme and endotoxin induced lung damage in the mouse. Thorax 1985 0.79
51 Nutrition in adults with cystic fibrosis. Clin Nutr 1998 0.78
52 Biological effects of 131I and 125I isotopes of iodine in the rat. J Endocrinol 1976 0.78
53 Repeatability and methodology of resting energy expenditure in patients with cystic fibrosis. Respir Physiol 1999 0.78
54 Metabolic and respiratory consequences of a glucose load in a hypoxic patient with cystic fibrosis. Ulster Med J 1992 0.77
55 Air-flow limitation in myasthenia gravis. The effect of acetylcholinesterase inhibitor therapy on air-flow limitation. Am Rev Respir Dis 1983 0.77
56 Can tumor necrosis factor-alpha (TNF-alpha) be reliably measured in blood? Pediatr Pulmonol 1995 0.77
57 The radiographic differentiation of pulmonary oedema. Br J Radiol 1989 0.77
58 Effect of monocrotaline ingestion on the distribution of protein and angiotensin converting enzyme activity in the rat lung. Thorax 1986 0.76
59 Plasma esterases in cystic fibrosis: the impact of a respiratory exacerbation and its treatment. Eur J Clin Pharmacol 1999 0.76
60 Viral infections: a role in the lung disease of cystic fibrosis? Thorax 1992 0.76
61 On tumor necrosis factor alpha in CF. Pediatr Pulmonol 1994 0.76
62 A short-term comparison of two methods of sputum expectoration in cystic fibrosis. Eur Respir J 2004 0.76
63 Respiratory arrests in young asthmatics on salmeterol. Respir Med 1994 0.75
64 Ulcerative colitis and sarcoidosis. Postgrad Med J 1986 0.75
65 Chest radiology in cystic fibrosis: is scoring useful? Thorax 1994 0.75
66 The cost of care in cystic fibrosis. Thorax 1992 0.75
67 OKT3 and pulmonary capillary permeability. Br Med J (Clin Res Ed) 1987 0.75
68 Endobronchial polyp in an asthmatic subject. Thorax 1983 0.75
69 Pulmonary function, serum markers of inflammation, and IgG antibodies to core lipopolysaccharide of Burkholderia cepacia in adults with cystic fibrosis, following colonization with Burkholderia cepacia. Pediatr Pulmonol 2000 0.75
70 Catecholaminergic interactions in the regulation of thyrotropin (TSH) secretion in man. J Endocrinol Invest 1980 0.75
71 An infertile female with ring (X) chromosome constitution and evidence of ovulation. Aust N Z J Obstet Gynaecol 1982 0.75
72 The report of Kaufman et al. on the relationship between agar gel double-diffusion and ELISA results for Aspergillus fumigatus IgG antibody. J Allergy Clin Immunol 1985 0.75
73 Systemic release of neutrophil elastase and tumour necrosis factor alpha following ABO incompatible blood transfusion. Br J Haematol 1991 0.75
74 Treatment response with bilateral mixed deafness and facial palsy in polyarteritis nodosa. Am J Med 1988 0.75
75 Candida albicans infection complicating percutaneous gastrostomy in cystic fibrosis. Br J Clin Pract 1995 0.75
76 Patient satisfaction with information provided at an outpatient clinic for respiratory diseases. Respir Med 1995 0.75
77 Proceedings: Evaluation of a rat thyrotrophin radioimmunoassay and its applications. J Endocrinol 1974 0.75
78 Suppression of plasma neutrophil elastase-alpha1-anti-proteinase complex by adequate replacement therapy in a patient with acquired hypogammaglobulinemia. J Allergy Clin Immunol 1997 0.75